Risk of fractures in patients with osteoporosis associated with chronic heart failure and type 2 diabetes mellitus

Daniial Chyngyshpaev; Orozaly Uzakov; Mairam Kerimaly kyzy; Sergey Shilov; Stalbek Akhunbaev; Aida Uzakova; Tugolbai Tagaev

doi:10.51248/.v43i5.3374

Authors

Daniial Chyngyshpaev
Orozaly Uzakov
Mairam Kerimaly kyzy
Sergey Shilov
Stalbek Akhunbaev
Aida Uzakova
Tugolbai Tagaev

DOI:

https://doi.org/10.51248/.v43i5.3374

Keywords:

Chronic heart failure, tumor necrosis factor-alpha, type 2 diabetes mellitus, postmenopausal women, loop diuretics

Abstract

Introduction and Aim: Although the pathophysiological processes underlying the association between congestive heart failure (CHF) and osteoporosis (OP) are unknown, there is evidence that several changes observed in CHF may play a role in bone loss. The objective of the study is to examine the impact of soluble TNF-alpha receptor 1 (sR1-TNF-alpha) and soluble TNF-alpha receptor 2 (sR2-TNF-alpha) on the risk of fractures in patients with OP associated with CHF and type 2 diabetes mellitus (T2DM).

Methods: This study included 178 women aged 50–65 years, divided into four groups. Group 1 consisted of 48 women diagnosed with HF and T2DM. Group 2 included 93 patients with OP and HF. Group 3 consisted of 37 women with OP, HF, and T2DM.

Results: The levels of sR1-TNF-alpha and sR2-TNF-alpha in patient groups 1 through 3 were significantly higher than in the control group (p<0.01). Furthermore, it was demonstrated that patients in group 3 had much greater levels of both receptors than those in groups 1 and 2.

Conclusion: High levels of sR1-TNF-alpha and sR2-TNF-alpha in postmenopausal women with CHF are associated with an increased risk of a poor outcome during OP.

Author Biographies

Daniial Chyngyshpaev

Administration of International Higher School of Medicine, Bishkek, Kyrgyzstan

Orozaly Uzakov

Administration of International Higher School of Medicine, Bishkek, Kyrgyzstan

Mairam Kerimaly kyzy

Administration of the Clinical Maternity Hospital No. 2, Bishkek, Kyrgyzstan

Sergey Shilov

Department of Special Psychology, Novosibirsk State Medical University, Novosibirsk, Russia

Stalbek Akhunbaev

Administration of International Higher School of Medicine, Bishkek, Kyrgyzstan

Aida Uzakova

Department of Obstetrics and gynecology, International Higher School of Medicine, Bishkek, Kyrgyzstan

Tugolbai Tagaev

Department of Hospital Internal Medicine, Occupational Pathology with a course of Hematology, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan

References

Ge, G., Li, J., Wang, Q. Heart failure and fracture risk: a meta-analysis. Osteoporos Int. 2019;30(10):1903-1909.

Abe, H., Semba, H., Takeda, N. The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb. 2017;24(9):884-894.

Arnett, T. R., Gibbons, D. C., Utting, J. C., Orriss, I. R., Hoebertz, A., Rosendaal, M., et al., Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol. 2003;196(1):2-8.

Mo, C., Ke, J., Zhao, D., Zhang, B. Role of the renin-angiotensin-aldosterone system in bone metabolism. J Bone Miner Metab. 2020;38(6):772-779.

Beavan, S., Horner, A., Bord, S., Ireland, D., Compston, J. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J Bone Miner Res. 2001;16(8):1496-1504.

Patel, R. B., Fonarow, G. C., Greene, S. J., Zhang, S., Alhanti, B., DeVore, A. D., et al., Kidney function and outcomes in patients hospitalized with heart failure. J Am Coll Cardiol. 2021;78(4):330-343.

Herrmann, M., Engelke, K., Ebert, R., Müller-Deubert, S., Rudert, M., Ziouti, F., et al., Interactions between muscle and bone-where physics meets biology. Biomolecules. 2020; 10(3):432.

Clynes, M. A., Gregson, C. L., Bruyère, O., Cooper, C., Dennison, E. M. Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology (Oxford). 2021;60(2):529-537.

Murzaevich, M. S., Imanalieva, F., Uulu, C. M., Tagaev, T., Yethindra, V., Arstanbekovna, M. Prevalence of osteopenia and osteoporosis in the Kyrgyz Republic. Indian J Forensic Med Toxicol. 2020;14(3):2016-2020.

Tagaev, T., Imanalieva, F., Mamatov, S., Vityala, Y., Zhumabekova, A. Prevalence of osteopenia and osteoporosis among the population of southern Kyrgyzstan - A cross-sectional observational study. Biomedicine (India). 2021; 41(4):742-746.

Jia, J., Zhou, H., Zeng, X., Feng, S. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. Mol Med Rep. 2017;15(4):1539-1546.

Pandey, A., Khan, Y. A., Kushwaha, S. S., Mohammed, F., Verma, A. Role of serum osteoprotegerin as a diagnostic indicator of primary osteoporosis in perimenopausal and postmenopausal women: An Indian Perspective. Malays Orthop J. 2018;12(1):31-35.

Aramburu-Bodas, Ó., García-Casado, B., Salamanca-Bautista, P., Guisado-Espartero, M. E., Arias-Jiménez, J. L., Barco-Sánchez, A., et al., Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction. J Cardiovasc Med (Hagerstown). 2015; 16(6):438-443.

Hanna, A., Frangogiannis, N. G. Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther. 2020;34(6):849-863.

Ing, S. W., Orchard, T. S., Lu, B., LaMonte, M. J., Barbour, K. E., Cauley, J. A., et al., TNF receptors predict hip fracture risk in the WHI study and fatty acid intake does not modify this association. J Clin Endocrinol Metab. 2015;100(9):3380-3387.

Kindle, L., Rothe, L., Kriss, M., Osdoby, P., Collin-Osdoby, P. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res. 2006;21(2):193-206.

Cauley, J. A., Danielson, M. E., Boudreau, R. M., Forrest, K. Y., Zmuda, J. M., Pahor, M., et al., Inflammatory markers and incident fracture risk in older men and women: The health aging and body composition study. J Bone Miner Res. 2007; 22(7):1088-1095.

Monaco, C., Nanchahal, J., Taylor, P., Feldmann, M. Anti-TNF therapy: past, present and future. Int Immunol. 2015; 27:55-62.

Fischer, R., Marsal, J., Guttà, C., Eisler, S. A., Peters, N., Bethea, J. R., et al., Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2. Sci Rep. 2017;7(1):6607.

Mann, D. L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91(11):988-998.

Hamid, T., Gu, Y., Ortines, R. V., Bhattacharya, C., Wang, G., Xuan, Y. T., et al., Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation. 2009; 119(10):1386-1397.

Lim, L. S., Fink, H. A., Kuskowski, M. A., Taylor, B. C., Schousboe, J. T., Ensrud, K. E., et al., Loop diuretic use and increased rates of hip bone loss in older men: The osteoporotic fractures in men study. Archives of Internal Medicine. 2008; 168(7): 735-740.

Monden, Y., Kubota, T., Inoue, T., Tsutsumi, T., Kawano, S., Ide, T., et al., Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am J Physiol Heart Circ Physiol. 2007; 293(1):H743-H753.

Heidrich, F. E., Stergachis, A., Gross, K. M. Diuretic drug use and the risk for hip fracture. Ann Intern Med. 1991;115(1):1-6.

Corrao, G., Mazzola, P., Monzio Compagnoni, M., Rea, F., Merlino, L., Annoni, G., et al., Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: A population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging. 2015; 32(11):927-936.

Lai, S. W., Cheng, K. C., Lin, C. L., Liao, K. F. Furosemide use and acute risk of hip fracture in older people: A nationwide case-control study in Taiwan. Geriatr Gerontol Int. 2017;17(12):2552-2558.

Rejnmark, L., Vestergaard, P., Heickendorff, L., Andreasen, F., Mosekilde, L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: Results from a randomized controlled study with bumetanide. J Bone Miner Res. 2006;21(1):163-170.